After Seelos Therapeutics’ amyotrophic lateral sclerosis (ALS) candidate failed a phase 2/3 study, the biotech has filed for ...

New Orleans Saints legend Steve Gleason is home and resting after what he calls a "traumatic accident" on Saturday. Gleason's wife Michel posted about the accident on his social media platforms saying ...

The world's largest ALS patient-derived stem cell and biodata repository is now available to researchers globally.

A grant from the ALS Association will fund an early-stage clinical trial to test Tiziana's foralumab nasal spray in 20 ALS ...

Canadian neurosurgeons in partnership with Elon Musk's Neuralink have regulatory approval to recruit six patients with ...

I pray that she carries the love that she felt tonight every day that she has," said friend Rita Monteiro, who organized the ...

Grammy winner John Driskell Hopkins, known as "Hop" from the Zac Brown Band, is turning his personal battle with amyotrophic ...

Dannce.ai emerged from stealth with a platform that aims to use artificial intelligence to help diagnose and monitor movement ...

Aimed at patients who are ineligible to take part in other clinical trials due to their advanced stage ALS, the trial hopes ...

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

Elon Musk's Neuralink has received Health Canada's approval to conduct its first clinical trial at Toronto Western Hospital, ...

Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...